No intervention
Otherjust descriptive analysis of clinical data
NCT Number: NCT04581096
One of the major problems in suppressing the spreading of an epidemic resides in understanding and monitoring its propagation patterns, and in evaluating how these are modified by enforced policies. The standard solution requires detailed information at the microscopic scales, e.g. how infected people have moved and whom they came in contact with, which is hardly ever available. The researchers propose a novel approach to the study of the propagation of COVID-19, in which a proxy of this information is derived at macroscopic scales. This will be based on two ingredients: the spatiotemporal study in shiny with mathematical models with aggregated or non aggregated data and the reconstruction of functional networks of spreading patterns, and the development of a supporting software.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
CHGUV, Valencia, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
just descriptive analysis of clinical data
Time frame: February 1, 2020 to September 30, 2020
spatiotemporal spread of COVID-19 patient in our hospital
Time frame: February 1, 2020 to September 30, 2020
risk classification score of each patients with clinical and analytical variables
Hospital General Universitario de Valencia
Other
Evaluation of the Response of COVID-19 Spread With a Spatiotemporal Analysis in a Tertiary Hospital
Acronym: MEDyMAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04606407
COVID-19, Coronaviridae Infections
Jerusalem, Israel
View Trial DetailsNCT04653727
COVID-19, Coronaviridae Infections
Berlin, Germany
View Trial DetailsNCT04860206
COVID-19, Cognition Disorders
Izola, Slovenia
View Trial DetailsNCT04649736
Behavior, COVID-19
Lima, Peru
View Trial Details